REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,770 | -87.0% | 939 | -71.3% | 0.00% | -100.0% |
| Q2 2023 | $82,840 | +108900.0% | 3,273 | +38.0% | 0.00% | +50.0% |
| Q1 2023 | $76 | +33.3% | 2,372 | -23.1% | 0.00% | 0.0% |
| Q4 2022 | $57 | -100.0% | 3,083 | -40.9% | 0.00% | 0.0% |
| Q3 2022 | $141,000 | +200.0% | 5,214 | +54.1% | 0.00% | +100.0% |
| Q2 2022 | $47,000 | +147.4% | 3,383 | +252.4% | 0.00% | – |
| Q1 2022 | $19,000 | -20.8% | 960 | -33.7% | 0.00% | – |
| Q4 2021 | $24,000 | -64.7% | 1,449 | -40.5% | 0.00% | -100.0% |
| Q3 2021 | $68,000 | -79.3% | 2,436 | -78.1% | 0.00% | -77.8% |
| Q2 2021 | $329,000 | +75.9% | 11,107 | +66.3% | 0.01% | +200.0% |
| Q1 2021 | $187,000 | +45.0% | 6,677 | +47.0% | 0.00% | -25.0% |
| Q4 2020 | $129,000 | -60.4% | 4,541 | -65.0% | 0.00% | 0.0% |
| Q3 2020 | $326,000 | +105.0% | 12,956 | +98.6% | 0.00% | -42.9% |
| Q2 2020 | $159,000 | +231.2% | 6,524 | +119.7% | 0.01% | +75.0% |
| Q4 2019 | $48,000 | +200.0% | 2,970 | +147.5% | 0.00% | +300.0% |
| Q3 2019 | $16,000 | +128.6% | 1,200 | +387.8% | 0.00% | – |
| Q2 2018 | $7,000 | +250.0% | 246 | +434.8% | 0.00% | – |
| Q4 2017 | $2,000 | -97.7% | 46 | -98.5% | 0.00% | -100.0% |
| Q3 2017 | $87,000 | +443.8% | 3,150 | +425.0% | 0.01% | +250.0% |
| Q2 2017 | $16,000 | +100.0% | 600 | +20.0% | 0.00% | +100.0% |
| Q3 2016 | $8,000 | +300.0% | 500 | +161.8% | 0.00% | – |
| Q2 2016 | $2,000 | -86.7% | 191 | -77.2% | 0.00% | -100.0% |
| Q1 2016 | $15,000 | +36.4% | 838 | +151.7% | 0.00% | +100.0% |
| Q2 2015 | $11,000 | -77.1% | 333 | -85.6% | 0.00% | -83.3% |
| Q1 2015 | $48,000 | +128.6% | 2,310 | +86.1% | 0.01% | +200.0% |
| Q4 2014 | $21,000 | -52.3% | 1,241 | -11.4% | 0.00% | -66.7% |
| Q1 2014 | $44,000 | – | 1,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |